Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-03-17 | 2021-05-19 | 135797 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2017-05-19 | 2019-03-09 | 10718 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2019-03-13 | 2024-12-10 | 78454 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2022-06-09 | 2022-07-12 | 162343 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-05-14 | 2019-08-31 | 84070 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-03-25 | 2020-04-29 | 109369 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| MOVISSE | 0.35MG | TABLET | Avoided shortage | 2017-10-18 | 2018-02-09 | 26211 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| MYL-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-06 | 2021-02-04 | 130906 |
| MYL-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-01-21 | 2025-03-03 | 248183 |
| MYL-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23160 |
| MYL-PROPAFENONE | 300MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23163 |
| MYL-SILDENAFIL | 100MG | TABLET | Avoided shortage | 2017-04-13 | 2017-07-17 | 6976 |
| MYL-SILDENAFIL | 50MG | TABLET | Resolved | 2017-04-04 | 2018-08-23 | 5307 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |